v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities:    
Net loss $ (2,471) $ (4,436)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 352 280
Non-cash lease activity   35
Bad debt expenses (recoveries) 17  
Deferred income tax (income) expense 30 6
Share-based compensation 182 907
Loss (gain) on disposal of equipment (15) (15)
Increase (decrease) in cash resulting from changes in:    
Trade accounts receivable 463 (10)
Inventories 274 (375)
Other current assets (81) 126
Other noncurrent assets (73) (37)
Trade accounts payable 128 404
Income taxes payable 1 (59)
Contract liabilities (362) (263)
Other current liabilities (75) (162)
Right of use liabilities   (35)
Accrued expenses (161) 468
Contract liabilities, noncurrent 103 (10)
Net cash provided by (used in) operating activities (1,688) (3,176)
Investing Activities:    
Capital expenditures (121) (435)
Proceeds from sale of equipment 20 15
Net cash provided by (used in) investing activities (101) (420)
Financing Activities:    
Proceeds from issuances of common stock   4,657
Tax payments associated with equity-based compensation transactions (24) (500)
Repayment of Legacy SMAP promissory note   (172)
Net cash provided by (used in) financing activities (24) 3,985
Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents (1,813) 389
Cash, cash equivalents, and restricted cash equivalents beginning of period 24,465 4,508
Cash, cash equivalents, and restricted cash equivalents end of the period 22,652 4,897
Reconciliation of cash, cash equivalents and restricted cash equivalents at end of period:    
Cash and cash equivalents 22,552 4,747
Restricted cash equivalents included in other current assets 100 150
Cash, cash equivalents, and restricted cash equivalents end of the period 22,652 4,897
Supplemental cash flow information:    
Income tax paid, net of refunds received $ 10 $ 110